According to Satya Nadella, Microsoft Research has introduced 'Gigatime', a cutting-edge platform that leverages multimodal AI to generate virtual populations for tumor microenvironment modeling. This advancement enables researchers to simulate complex biological interactions at scale, significantly accelerating oncology drug discovery and personalized medicine development. By integrating large-scale data and AI-driven insights, Gigatime addresses critical bottlenecks in preclinical cancer research, offering life sciences companies new tools to optimize treatment strategies and reduce R&D timelines (source: microsoft.com/en-us/research/blog/gigatime-scaling-tumor-microenvironment-modeling-using-virtual-population-generated-by-multimodal-ai/).